Skip to main content Back to Top
Advertisement

9/3/2019

Cefoxitin Sodium Injection

Products Affected - Description

    • Cefoxitin powder for solution for injection, Apotex, 1 gram, vial, 25 count, NDC 60505-0759-05
    • Cefoxitin powder for solution for injection, Apotex, 10 gram, vial, 10 count, NDC 60505-0761-04
    • Cefoxitin powder for solution for injection, Apotex, 2 gram, vial, 25 count, NDC 60505-0760-05
    • Cefoxitin powder for solution for injection, Fresenius Kabi, 1 gram, 15 mL vial, 25 count, NDC 63323-0341-25
    • Cefoxitin powder for solution for injection, Fresenius Kabi, 2 gram, 20 mL vial, 25 count, NDC 63323-0342-25
    • Cefoxitin powder for solution for injection, Hikma, 1 gram, vial, 25 count, NDC 00143-9878-25
    • Cefoxitin powder for solution for injection, Hikma, 2 gram, vial, 25 count, NDC 00143-9877-25
    • Cefoxitin powder for solution for injection, Sagent, 1 gram, vial, 25 count, NDC 25021-0109-10
    • Cefoxitin powder for solution for injection, Sagent, 10 gram, vial, 10 count, NDC 25021-0111-99
    • Cefoxitin powder for solution for injection, Sagent, 2 gram, vial, 25 count, NDC 25021-0110-20
    • Cefoxitin powder for solution for injection, WG Critical Care, 1 gram, vial, 25 count, NDC 44567-0245-25
    • Cefoxitin powder for solution for injection, WG Critical Care, 2 gram, vial, 25 count, NDC 44567-0246-25
    • Cefoxitin powder for solution for injection, BBraun, 2 gram, 50 mL DUPLEX Drug Delivery System, 24 count, NDC 00264-3125-11
    • Cefoxitin powder for solution for injection, BBraun, 1 gram, 50 mL DUPLEX Drug Delivery System, 24 count, NDC 00264-3123-11

Reason for the Shortage

    • Apotex has temporarily discontinued cefoxitin vials.
    • BBraun has cefoxitin on allocation due to increased demand.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage. Hikma is not currently marketing cefoxitin 10 gram vials.
    • Sagent has cefoxitin on shortage due to increased demand and manufacturing delay.
    • WG Critical Care did not provide a reason for the shortage.

Available Products

    • Cefoxitin powder for solution for injection, Fresenius Kabi, 10 gram, 100 mL bottle, 10 count, NDC 63323-0343-66
    • Cefoxitin powder for solution for injection, WG Critical Care, 10 gram, vial, 10 count, NDC 44567-0247-10

Estimated Resupply Dates

    • Apotex has temporarily discontinued cefoxitin 1 gram, 2 gram, and 10 gram vials and the company cannot estimate when product will be available again.
    • BBraun has cefoxitin 1 gram and 2 gram DUPLEX bags on back order and the company cannot estimate a next release date.
    • Fresenius Kabi has cefoxitin 1 gram and 2 gram vials on back order and the company estimates a release date of mid-September 2019.
    • Hikma has cefoxitin 1 gram vials on back order and the company estimates a release date in late-October 2019. The 2 gram vials are on allocation. The 10 gram vials are on back order and the company estimates a release date of January 2020.
    • Sagent has cefoxitin 1 gram vials on allocation. The 2 gram and 10 gram vials are on back order and the company estimates a release date of September 2019.
    • WG Critical Care has cefoxitin 1 gram and 2 gram vials on back order and the company estimates a release date of mid- to late-September 2019.

Updated

Updated September 3, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 8, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins